Search
GeneDx Holdings Corp
WGSAdd to Watchlist
71.710USD
+3.060+4.46%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
2.13BMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+4.46%
5 Days
+12.86%
1 Month
+37.90%
6 Months
-44.86%
Year to Date
-44.86%
1 Year
-20.58%
Key Figures
69.000Open
71.760High
721.80KVolume
LossP/E TTM
51.33P/E Dynamic
--Dividend TTM
2.43%Turnover Ratio
68.650Prev. Close
68.410Low
35.42MTurnover
LossP/E Static
8.37P/B
0.00%Div Yield TTM
-16.33%ROA
170.87052wk High
0.65Volume Ratio
-52.29MNet Profit
29.67MShares
-2.6604EPS TTM
1.99Beta
-30.42%ROE
32.21052wk Low
4.88%Amplitude
66.71%Gross Margin
2.13BMarket Cap
7.24Reward/Risk
4.03%Risk Rate
TradingKey Stock Score of GeneDx Holdings Corp
Currency: USD Updated: 2026-06-30Key Insights
GeneDx Holdings Corp's fundamentals are relatively healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 13 out of 76 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 89.56.In the medium term, the stock price is expected to remain stable.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
GeneDx Holdings Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
GeneDx Holdings Corp Highlights
StrengthsRisks
GeneDx Holdings Corp. is a genomics company. The Company operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. It offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 111.06% year-on-year.
Undervalued
The company’s latest PE is -25.80, at a low 3-year percentile range.
Held by Catherine Wood
Star Investor Catherine Wood holds 1.76M shares of this stock.
Analyst Rating
Based on
9
analysts
Buy
Current Rating
89.556
Target Price
+30.45%
Upside Space
GeneDx Holdings Corp News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
GeneDx Holdings Corp Info
GeneDx Holdings Corp. is a genomics company. The Company operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. It offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.
Ticker SymbolWGS
CompanyGeneDx Holdings Corp
CEOStueland (Katherine A)
Websitehttps://sema4.com/
Related Instruments
+2.62%
+2.41%
+1.57%
+1.18%
+1.73%
+1.30%
-0.50%
+1.27%
+7.60%
+0.88%
+0.39%
+0.89%
+1.92%
+1.70%
+3.09%
+2.12%
+1.08%
+1.78%
+0.41%
+0.78%Popular Instruments
FAQs
What is the current price of GeneDx Holdings Corp (WGS)?
The current price of GeneDx Holdings Corp (WGS) is 71.71.
What is the symbol of GeneDx Holdings Corp?
The ticker symbol of GeneDx Holdings Corp is WGS.
What is the 52-week high of GeneDx Holdings Corp?
The 52-week high of GeneDx Holdings Corp is 170.87.
What is the 52-week low of GeneDx Holdings Corp?
The 52-week low of GeneDx Holdings Corp is 32.21.
What is the market capitalization of GeneDx Holdings Corp?
The market capitalization of GeneDx Holdings Corp is 2.13B.
Is GeneDx Holdings Corp (WGS) currently rated as Buy, Hold, or Sell?
According to analysts, GeneDx Holdings Corp (WGS) has an overall rating of Buy, with a price target of 89.56.
What is the Earnings Per Share (EPS TTM) of GeneDx Holdings Corp (WGS)?
The Earnings Per Share (EPS TTM) of GeneDx Holdings Corp (WGS) is -0.73.